. Concentration values on the x-axis of T and U are given as log micromolar. Cpd. 5 was also assayed at α 1A,B,D ARs, α 2A,B,C ARs, and 5HT 1A -these targets were predicted, but found out later to be known. [9] [10] [11] In our hands, affinities of cpd. 5 at these targets were 0. 
SUPPLEMENTARY METHODS
Zebrafish behavioral pharmacology. Embryos were collected from group matings of Ekwill or TuAB zebrafish and raised in HEPES (10 mM) buffered E3 media in a dark 28 °C incubator. At 28 hpf, groups of 8-10 embryos were distributed into the wells of a 96 well plate.
Compound stocks were diluted into each well at the specified concentration and allowed to incubate for 1 hour.
To assay the PMR, 1000 frames of digital video were recorded at 33fps using a
Hamamatsu ORCA-ER camera attached to a Nikon TE200 microscope at 1X magnification.
Light stimuli (1s)-from a 300Watt xenon bulb housed in a Sutter Lambda LS illuminator-were delivered 10s and 20s after the start of the video. Instrument control and data measurement were performed using custom programs for Metamorph Software (Universal Imaging). Each video was saved for review.
To analyze digital video recordings, custom software scripts (Metamorph) were used to automatically draw six evenly spaced line segments across the well such that each embryo is To treat zebrafish with chemicals, stock solutions in DMSO were added to each well, mixed, and allowed to incubate for 1h. Final DMSO concentrations were <1%. In experiments with multiple compounds, the compounds were added simultaneously. Fig. 2) . As an additional guide during visual inspection, targets were annotated with biological process information from the Gene Ontology (GO) database (http://www.geneontology.org) and pathway information from the Reactome database (http://www.reactome.org).
Ligands selected for target identification. Selected hits from our SEA prediction that passed a visual inspection and had testable targets were sourced from the following commercial vendors: compounds 1, 3, 4, 6-8, 10, 11, and 52, 54, 55, 58, and 60 were ordered from ChemBridge, compound 2 from Life Chemicals, compound 5 from Tocris, compounds 9, 56, and 57 from Sigma-Aldrich, compound 53 from MP Biomedicals, and compound 59 from Otava
Chemicals. All compounds were sourced at 95% or greater purity as described by the vendors.
All active compounds were further tested at UCSF for purity by LC/MS, and all were found to be pure as judged by peak height and identity. For the phenocopy and phenotype inversion experiments, compounds 12 and 13 were sourced from Sigma-Aldrich and compound 14 from Enzo Life Sciences, at 98% or greater purity grades.
Radioligand competition binding assays of compounds 1-5, 8, 52 and 53. Crude P2
(21,000 x g) membrane preparations were prepared from cell lines expressing (either stably or transiently) recombinant human GPCRs using 50 mM Tris, 1% BSA, pH 7.4 at a concentration of ca. 50 μg protein/μL (assayed by Bradford assay using BSA as a standard). Next, 50 μL of membrane suspension were added to the wells of a 96-well plate containing 100 μL of binding assay buffer, 50 μL of radioligand at a concentration equal to five times the dissociation constant (K d ) for the receptor being assayed, and 50 μL of test drug or reference compound at a concentration equal to five times the desired assay concentration (Supplementary Table 4 ).
Reactions were incubated for 60 to 90 min at room temperature in the dark, and then harvested onto 0.3% PEI-treated GF/A filtermats (Wallac). After three washes with ice-cold wash buffer (50 mM Tris, pH 7.4), filter mats were dried in a microwave oven and impregnated with Meltilex scintillant (Wallac). Residual binding of radioligand, measured by scintillation counting using a TriLux microbeta counter (Wallac), was fit to the one-site radioligand competition binding model MSA; Carna Biosciences) were added to the well. The reaction mixture was applied to a LabChip3000 system (Caliper Life Science), and the product and substrate peptide peaks were separated and quantitated. Substrate-to-product conversion was calculated from the peak heights of the product(P) and substrate(S) peptides as P/(P+S). Detailed reaction conditions are given in Supplementary 
